View Post

Rare Patient Voice Research opportunity for Chronic Lymphocytic Leukemia Patients and Caregivers living in Canada

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 90 min web-assisted phone interview (plus homework) Please sign up at the link below to receive an email invite to the survey.  Compensation CAD 240 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and …

View Post

Rare Patient Voice: Research opportunity for Chronic Lymphocytic Leukemia (CLL) patients and caregivers living in the United States

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 30 min web-assisted phone interview US only Compensation $75 Please sign up at the link below to receive an email invite to the survey.  Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are …

View Post

Rare Patient Voice: Research opportunity for Chronic Lymphocytic Leukemia (CLL) patients (living in the United States)

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 60 min web-assisted phone interview US only Compensation $100 Please sign up at the link below to receive an email invite to the survey.  Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are …

View Post

Rare Patient Voice: Research opportunity for patients and caregivers that have been diagnosed with one or more of the following conditions

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Criteria: Research opportunity for patients and caregivers that have been diagnosed with one or more of the following conditions: Multiple Myeloma, Chronic Lymphocytic Leukemia, Breast Cancer, Prostate Cancer, Rheumatoid Arthritis. Details: 20 min online survey Compensation $35 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, …

View Post

Rare Patient Voice: Research opportunity for Chronic Lymphocytic Leukemia (CLL) patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 6 hour Video Focus Group broken into 2 three hour sessions Compensation $600 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and …

View Post

Rare Patient Voice: Study Opportunity for Chronic Lymphocytic Leukemia (CLL) Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! …

View Post

Rare Patient Voice: Study Opportunity for Chronic Lymphocytic Leukemia Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 10 minute Online Survey Compensation $35 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …

View Post

FDA Approves Acalabrutinib for CLL

In Clinical Studies News by Barbara Jacoby

By: Jason M. Broderick From: onclive.com The FDA has approved acalabrutinib (Calquence) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).1,2 The approval, which was done under the FDA’s Project Orbis initiative, was based on 2 phase III randomized trials—ELEVATE-TN and ASCEND. “Today, as part of a US, Australian, and Canadian collaboration known …

View Post

Dynamic duo in Pinehurst appreciates opportunity to participate in clinical trial

In Clinical Studies News by Barbara Jacoby

From: sandhillssentinel.com While FirstHealth of the Carolinas has earned widespread acclaim as a national leader in community health, Sandhills residents may not know of a superpower within the system that offers opportunities for patients in the region and worldwide: its extensive clinical trials program. “FirstHealth offers a wide array of clinical trials that far exceeds the average for regional medical …

View Post

JHL Biotech Announces First Patient Randomized in the Phase III Study of JHL1101 to Treat Diffuse Large B-Cell Lymphoma

In Clinical Studies News by Barbara Jacoby

Source: JHL Biotech From: prnewswire.co.uk JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in the Phase III study of JHL1101 to treat diffuse large B-cell lymphoma (DLBCL). The Phase III study is a multinational, randomized, double-blind, positive-controlled, parallel group clinical study.  It compares the efficacy and safety of JHL1101 in combination with CHOP …